Related Experiment Video
Updated: Jun 13, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.1K
Enhancing early Parkinson's disease detection through multimodal deep learning and explainable AI: insights from the
Vincenzo Dentamaro1, Donato Impedovo2, Luca Musti2
1Dipartimento di Informatica, University of Bari Aldo Moro, 70125, Bari, Italy. vincenzo.dentamaro@uniba.it.
Scientific Reports
|September 9, 2024
Summary
This study uses multimodal deep learning to detect early Parkinson's Disease (PD). Combining imaging and clinical data with AI, it identifies key brain regions for early diagnosis and precision medicine.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Imaging
Background:
- Parkinson's Disease (PD) is a common neurodegenerative disorder affecting millions globally.
- Early detection of PD is crucial for effective management and treatment.
Purpose of the Study:
- To investigate multimodal deep learning for prodromal Parkinson's Disease detection.
- To integrate imaging and clinical data using a novel co-learning approach.
- To enhance diagnostic accuracy through Explainable AI (XAI) techniques.
Main Methods:
- Utilized the Parkinson's Progression Markers Initiative (PPMI) dataset.
- Developed a joint co-learning framework for multimodal data fusion in deep neural networks.
- Employed 3D Convolutional Neural Networks (CNNs) with Excitation Networks (EN) and Vision Transformers (ViT).
- Applied XAI methods like Integrated Gradients and Attention Heatmaps for model interpretability.
Main Results:
- DenseNet with EN demonstrated superior performance, significantly improving accuracy when clinical data was included.
- XAI analysis revealed DenseNet's focus on critical brain regions (right temporal, left pre-frontal) for prodromal PD.
- ViT highlighted the lateral ventricles, potentially linked to cognitive decline in early PD stages.
Conclusions:
- The proposed multimodal deep learning framework effectively aids in early PD diagnosis and subtype prediction.
- Identified brain regions and lateral ventricles show promise as early biomarkers for Parkinson's Disease.
- Findings support the development of advanced diagnostic tools for precision medicine in neurodegenerative diseases.
Related Concept Videos
Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498

